CYTOKINETICS, INCORPORATED (CYTK) Free cash flow 2016–2025
CYTOKINETICS, INCORPORATED (CYTK) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$534.8MFY2025 · since FY2016: $35.4M → -$534.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$534.8M | -33.8% |
| FY2024 | -$399.8M | +3.8% |
| FY2023 | -$415.7M | -33.7% |
| FY2022 | -$310.9M | -62.4% |
| FY2021 | -$191.4M | -8975.1% |
| FY2020 | -$2.1M | +97.7% |
| FY2019 | -$93.5M | +8.4% |
| FY2018 | -$102.1M | +2.4% |
| FY2017 | -$104.6M | -395.7% |
| FY2016 | $35.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CYTK financial trends
CYTK RevenueCYTK Net incomeCYTK Net marginCYTK Gross profitCYTK Gross marginCYTK Operating incomeCYTK Operating marginCYTK Operating cash flowCYTK Capital expendituresCYTK Return on equityCYTK Stock buybacksCYTK Dividends paidCYTK Total assetsCYTK Total liabilitiesCYTK Shareholders’ equityCYTK overview →